Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
about
Allelic heterogeneity at the equine KIT locus in dominant white (W) horsesDepression in patients with mastocytosis: prevalence, features and effects of masitinib therapyApatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transportersA G-Rich Sequence within the c-kit Oncogene Promoter Forms a Parallel G-Quadruplex Having Asymmetric G-Tetrad DynamicsMutation D816V alters the internal structure and dynamics of c-KIT receptor cytoplasmic region: implications for dimerization and activation mechanismsHotspot mutations in KIT receptor differentially modulate its allosterically coupled conformational dynamics: impact on activation and drug sensitivityEvidence for intermolecular interactions between the intracellular domains of the arabidopsis receptor-like kinase ACR4, its homologs and the Wox5 transcription factorA melanoma molecular disease modelMolecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications.RIN3 is a negative regulator of mast cell responses to SCF.Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report.KIT is required for hepatic function during mouse post-natal development.A novel melting curve-based method for detecting c-kit mutations in acute myeloid leukemia.Identification of novel target genes of nerve growth factor (NGF) in human mastocytoma cell line (HMC-1 (V560G c-Kit)) by transcriptome analysis.Identification of heptapeptides interacting with IFN-α-sensitive CML cells.Glycogen synthase kinase 3beta activation is a prerequisite signal for cytokine production and chemotaxis in human mast cellsThe preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders.Kit inhibitor APcK110 extends survival in an AML xenograft mouse modelCore-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferationOncogenic Kit signals on endolysosomes and endoplasmic reticulum are essential for neoplastic mast cell proliferation.Gastrointestinal stromal tumor - an evolving concept.Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.Oncolytic reovirus in canine mast cell tumor.c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice.Role of intracellular tyrosines in activating KIT-induced myeloproliferative diseaseInhibition of ovarian KIT phosphorylation by the ovotoxicant 4-vinylcyclohexene diepoxide in ratsGlycogen synthase kinase-3β is a prosurvival signal for the maintenance of human mast cell homeostasisDistinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia.Targeted agents for the treatment of metastatic melanoma.Dissecting protein architecture with communication blocks and communicating segment pairs.Identification of the two KIT isoforms and their expression status in canine hemangiosarcomas.M-COPA suppresses endolysosomal Kit-Akt oncogenic signalling through inhibiting the secretory pathway in neoplastic mast cells.Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.Process map proposal for the validation of genomic biomarkers.Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice.Expression and function of hematopoiesis-stimulating factor receptors on the GPI(-) and GPI(+) hematopoietic stem cells of patients with paroxysmal nocturnal hemoglobinuria/aplastic anemia syndrome.Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.Tumor-associated antigens and biomarkers in cancer and immune therapy.
P2860
Q21090217-2671DE10-1A23-4C0C-BFAB-1CBB95BA4D55Q21560915-39884109-3C76-4458-AE07-739D01510C20Q24617999-4F455621-6BF7-4851-AAD6-BED5BEDBECA1Q27657150-09F0F064-F14E-4138-ACCC-827C3B5EDE3AQ28478611-1E522DAF-F963-4E82-9C2D-945395F3485AQ28541374-BEACA073-60EB-47E8-979A-12CE47C11274Q28543936-D319FC66-D831-41DD-84D8-BA6A03B36F51Q28741507-59F9D5C9-1F07-4345-8652-AC215347B91AQ30245586-9C847327-4845-4EE5-9DF9-D5A997FCAFB1Q30423833-BDB01D84-6367-48BA-85A8-A1E27740FE60Q33269497-D988B848-6416-437E-AB8F-43FEB80674E6Q33289995-F259E5EF-DC67-40DB-AFF1-6857E2403FB7Q33778329-A4AD3B9C-1270-4F79-BB7E-1678D9EAEC65Q33875795-61FC4946-DDEE-4826-9641-4D12F3906B4FQ34076524-95270CA3-36DE-4015-8732-DEC4E305CB16Q34214029-C49E6885-7711-4589-A86E-975D1E8A14B8Q34353920-A66E18BF-9104-4FE3-A082-7AF7698D480CQ34610623-02A2C283-0160-45EB-91B9-E993DEF3AE02Q34663691-35821789-CFAD-4D3E-9417-257C1A9A69C0Q34674610-11DCB6DC-C316-4BA1-BA6B-5BB39967FB94Q34774009-B58F8BA7-F497-442D-9376-B726ADF60B0EQ34833416-3A858048-B9C1-4C2F-9A48-21B353356F30Q34928165-F2C6F881-4DCA-4C31-BEEE-F543A96DE25AQ34943036-9AFB7254-1BD7-441C-9EA9-463667C8C314Q35000631-484AD918-B408-40E8-A802-55470DFDED31Q35107232-67E35E16-48A1-4E3E-9981-A073854D95FEQ35230318-8C54BE3D-A972-41B5-99BE-AE251B5D2C48Q35249960-8D53A772-E829-4293-8FBA-2C97646A19ACQ35566591-EF935C16-3649-4C03-9C64-FCC200D67D80Q35776442-AEF26468-098A-43A1-A166-E638D96FF15EQ35822194-56C8BF09-940E-4D94-8A6F-A9A30104389FQ35907927-9ADF799A-EB31-4272-A4CC-8C5E74F43926Q36078994-AF94C5EF-CA16-4F9D-A6C2-014106334C64Q36344903-F4C19CA0-94D5-43A1-BED6-752BA3824633Q36461618-BE394EDA-1319-4F9F-BA9B-C30BED3411FEQ36555934-8A978640-5DAC-4160-ACCD-9E7A2DF999EAQ36807804-D5709F2D-7CF2-43B2-8377-FE6EB6F0DAB3Q36824622-5817F556-0EDE-4282-8635-9DB994BCFC0DQ36842503-2CAC1D04-312B-469A-A50D-2AB0102139A2Q36844959-0C343D9C-F707-437A-84C9-2BBE40BEF28A
P2860
Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
@ast
Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
@en
type
label
Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
@ast
Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
@en
prefLabel
Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
@ast
Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
@en
P1476
Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
@en
P304
P356
10.1016/J.BBRC.2005.09.150
P407
P577
2005-10-04T00:00:00Z